|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/706 | (2006.01) |
| A61K 31/53 | (2013.01) | ||
| A61P 31/12 | (2006.01) | ||
| C07H 1/00 | (2013.01) | ||
| C07D 487/04 | (2006.01) | ||
| C07H 1/02 | (2013.01) | ||
| C07D 519/00 | (2006.01) | ||
| C07H 11/00 | (2013.01) | ||
| C07H 1/00 | (2006.01) | ||
| C07H 15/18 | (2013.01) | ||
| C07H 1/02 | (2006.01) | ||
| A61K 31/6615 | (2013.01) | ||
| A61K 31/665 | (2013.01) | ||
| C07H 11/00 | (2006.01) | ||
| C07H 15/18 | (2006.01) | ||
| A61K 31/683 | (2013.01) | ||
| A61K 31/706 | (2013.01) | ||
| A61K 31/7056 | (2013.01) | ||
| C07D 487/04 | (2013.01) | ||
| C07D 519/00 | (2013.01) | ||
| A61K 31/675 | (2013.01) | ||
| A61K 31/685 | (2013.01) | ||
| A61P 31/00 | (2018.01) | ||
| A61P 31/12 | (2018.01) | ||
| A61P 31/14 | (2018.01) | ||
| A61P 43/00 | (2018.01) | ||
| Y02P 20/55 | (2015.11) | ||
| Y02A 50/30 | (2018.01) |
| (11) | Number of the document | 3695844 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20152978.1 |
| Date of filing the European patent application | 2015-10-29 | |
| (97) | Date of publication of the European application | 2020-08-19 |
| (45) | Date of publication and mention of the grant of the patent | 2025-04-02 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201462072331 P | 2014-10-29 | US | |
| 201562105619 P | 2015-01-20 | US |
| (72) |
CHUN, Byoung, Kwon , US
CLARKE, Michael, O'Neil Hanrahan , US
DOERFFLER, Edward , US
HUI, Hon, Chung , US
JORDAN, Robert , US
MACKMAN, Richard, L. , US
PARRISH, Jay, P. , US
RAY, Adrian, S. , US
SIEGEL, Dustin , US
|
| (73) |
Gilead Sciences, Inc. ,
333 Lakeside Drive, Foster City, CA 94404,
US
|
| (54) | A REMDESIVIR COMPOUND FOR USE IN TREATING NIPAH VIRUS INFECTIONS |
| A REMDESIVIR COMPOUND FOR USE IN TREATING NIPAH VIRUS INFECTIONS |